Ponentes

Andrea Calcagno, MD, DTM&H.
Andrea Calcagno, MD, DTM&H.

He is temporary Assistant Professor at the University of Torino (Department of Medical Sciences, Infectious Diseases). Infectious Diseases Specialist (University of Torino, Italy); Diploma in Tropical Medicine and Hygiene (Mahidol University, Bangkok, Thailand). He is member of the Panel of the Italian Guidelines on the Use of Antiretrovirals and Management of patients living with HIV.

He has experience as a Clinicians in Infectious Diseases and Tropical Medicine (Sudan, Thailand, Burundi); several phase II, III and IV studies in antiretroviral treatment trials.

His main field of interest is the clinical pharmacology and pharmacogenetics of anti-infective agents (antiretroviral, antibiotic, antifungals) and the central nervous system complication of HIV-infection.

Paola Cinque, MD, Ph. D.
Paola Cinque, MD, Ph. D.

She is currently working as senior physician at the Department of Infectious Diseases and responsible of the Neurovirology Research Unit at the Research Division of Immunology, Transplantation and Infectious Diseases of San Raffaele Scientific Institute, Milan, Italy, and as contract Professor of Infectious Diseases at San Raffaele University.

Her research group is mainly involved in studies on HIV Infection of the Central Nervous System, Progressive Multifocal Leukoencephalopathy and other HIV-associated CNS complications.

She is a panel member of the Italian HIV Treatment Guidelines, of the EACS Co-morbidities and of the Opportunistic Infections Guidelines, and of the NIH/CDC/IDSA Guidelines for the Prevention and Treatment of Opportunistic Infections.in HIV-Infected Adults and Adolescents.

Guida da Ponte, Ph. D.
Guida da Ponte, Ph. D.

Guida da Ponte is a Psychiatry Consultant, Coordinator of Liaison Psychiatry Unit, in Centro Hospitalar Barreiro-Montijo, located in the suburban area of Lisbon, Portugal. One of the major fields of practice is with HIV patients with a psychiatric outpatient clinic dedicated to this condition. Author of scientific publications, mainly in the areas of neurocognitive disorders, depression, anxiety and psychopharmacology and antiretroviral interactions. Other major area of interest is Psycho-Oncology, as PhD student of Medical School of Lisbon, University of Lisbon.

Sarah Joseph, MD
Sarah Joseph, MD
Dr. Sarah Joseph is a virologist and evolutionary biologist with extensive experience examining the evolution of HIV-1 in the CNS and its effects on neurocognition. Dr. Joseph received her Ph.D. from the University of Texas at Austin and was a postdoc at the University of North Carolina where she is now an Assistant Professor in the Department of Microbiology & Immunology. Dr. Joseph utilizes both traditional and next generation sequencing techniques to characterize HIV-1 populations in patient samples and to infer information about the evolutionary pressures shaping HIV-1 populations in different compartments of the body. This approach has revealed important information about the nature of HIV-1 transmission, viral colonization of the CNS and the establishment of viral reservoirs.
Ken Kunisaki, MD
Ken Kunisaki, MD
Dr. Kunisaki is a respiratory physician, Associate Professor of Medicine at the University of Minnesota, and a Staff Physician at the Minneapolis Veterans Affairs Health Care System. Dr. Kunisaki completed medical school at The Ohio State University, followed by training at the University of Minnesota that included a residency in Internal Medicine and Pediatrics, a fellowship in Adult Pulmonary and Critical Care Medicine, and a MS degree in Clinical Research. His academic research work is focused on clinical trials and observational studies in lung disease and sleep disorders, with a particular interest in HIV-associated lung and sleep health. He was Principal Investigator of the NIH-funded Pulmonary Substudy of the START randomized trial of immediate vs deferred ART initiation and he is currently PI of the NIH-funded Sleep Substudy in the POPPY cohort, a UK-based observational cohort addressing comorbidities of aging with HIV.
Scott Letendre, MD.
Scott Letendre, MD.

Scott Letendre, M.D., is Professor of Medicine in Residence in the Division of Infectious Diseases at the University of California, San Diego (UCSD). He graduated from Georgetown University School of Medicine and, following his residency in internal medicine at the Naval Medical Center in San Diego, he completed fellowships in Infectious Disease Medicine at Duke University and in Neurologic HIV Research at UCSD. At UCSD, Dr. Letendre performs translational, patient-oriented research of the central nervous system complications of chronic infections, including HIV, HCV, and CMV. As part of a multidisciplinary research team, he conducts treatment trials of neurocognitively impaired individuals and analyzes their response to therapy as well as studies of the pharmacokinetics of antiretrovirals, the effect of comorbidities, and biomarker correlates of disease. Dr. Letendre is also an investigator in the UCSD unit of the AIDS Clinical Trials Group.

He participates in several international research projects, including projects based in China, India, Zambia, and Romania. Dr. Letendre balances his research activities with regular, clinical outpatient and inpatient care of people living with HIV and other infectious diseases. Dr. Letendre also teaches in the Microbiology course at the UCSD School of Medicine and chairs the UCSD Institutional Biosafety Committee. Dr. Letendre has published in several peer-reviewed journals including AIDS, Clinical Infectious Diseases, Journal of Infectious Diseases, Neurology, Journal of Virology, Journal of Neurovirology, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, and Journal of Neuroimmunology.

Catia Marzolini, PharmD PhD
Catia Marzolini, PharmD PhD

Dr Catia Marzolini obtained a degree in Pharmacy followed by a PhD in Clinical Pharmacology at the University of Lausanne, Switzerland. She completed a post-doctoral fellowship in the pharmacogenetics of drug transporters within the Division of Clinical Pharmacology at Vanderbilt University, Nashville, USA. She obtained subsequently the “venia docenti” from the University of Basel.

Catia Marzolini is currently working as a senior research scientist in the Division of Infectious Diseases & Hospital Epidemiology at the University Hospital of Basel. Her research focuses on pharmacological and genetic determinants of antiretroviral drug response and toxicity. Catia Marzolini has become an expert in the field of HIV drug-drug interactions. She is a member of the Liverpool HIV drug-drug interactions website and is notably in charge of predicting drug-drug interactions. Catia Marzolini has also joined the European AIDS Clinical Society (EACS) guidelines committee panel for the pharmacological aspects of HIV therapy.

Cynthia Monaco, MD, PhD
Cynthia Monaco, MD, PhD
Dr. Monaco received her MD and PhD degrees at University of Texas Southwestern Medical Center in Dallas, and her Internal Medicine Residency and Infectious Diseases Fellowship at Washington University in St. Louis. She continued there as faculty in the Department of Medicine at Washington University from 2015 to 2017. She then joined the faculty of the Division of Infectious Diseases at the University of Rochester Medical Center in 2017, where she continues to pursue microbiome research and sees inpatient ID consults. Dr. Monaco's research involves elucidating components of the bacterial and viral microbiome in healthy and disease states using next-generation sequencing. She has shown that severe immunodeficiency in AIDS correlated with an expanded enteric virome and altered bacterial microbiome in a sub-Saharan cohort. She additionally is collaborating with colleagues at other institutions to study the lung microbiome in transplant recipients.
Jose A. Muñoz-Moreno, Ph. D.
Jose A. Muñoz-Moreno, Ph. D.

Jose A. Muñoz-Moreno is a clinician and researcher at the Lluita contra la SIDA Foundation, located in the Germans Trias i Pujol University Hospital, in Barcelona (Catalonia, Spain). He earned the Ph.D. degree in Neurosciences in 2012 (Cum Laude), and currently he is also a collaborating professor with the Universitat de Barcelona (UB) and the Universitat Autònoma de Barcelona (UAB).

Muñoz-Moreno is involved in projects that address psychology and the human behaviour associated with HIV infection. In terms of study, he mostly investigates the neurocognitive features of HIV infection, the impact of HIV and antiretroviral treatments on quality of life and emotional status, and adherence to antiretroviral therapy.

Muñoz-Moreno’s recent work particularly focuses on assessment methods to detect HIV-related neurocognitive changes and the current profile of neurocognitive impairment in people living with HIV infection.

Mark Pakianathan, MD
Mark Pakianathan, MD
Dr Mark Pakianathan is Consultant Physician in HIV Medicine & Sexual Health at Guy’s & St Thomas’ NHS Trust where he leads on Sexual & Gender Diversity Sexual Health within a large HIV treatment centre and open access sexual health service. He has over 25 years of experience of working in Sexual Health mostly in London where his career has had a strong focus on working with marginalised populations including inner city youth, sex workers and prisoners. He has a research interest in Chemsex and in his career pioneered specialist co-located services for sexual health and substance use disorders for gay, bisexual and other men who have sex with men in South London. He has also developed and run experiential training on Chemsex clinical communication which was replicated as a resource for training professionals across Europe.  He is a strong advocate for holistic compassionate care
Luis F. Pereira, MD
Luis F. Pereira, MD
Dr. Pereira graduated from the Faculty of Medicine of the University of Lisbon, Portugal, in 2004, and completed a 5-year residency program in Internal Medicine in 2011. Because of his interest in HIV infection, he obtained a Master's Degree in HIV/AIDS in 2009 from the University of Barcelona, Spain. In 2017, he graduated from Mount Sinai Beth Israel's Psychiatry Residency Program and in 2018 completed a fellowship in Consultation-Liaison Psychiatry at Columbia University Irving Medical Center/New York-Presbyterian Hospital, New York. He is currently an Assistant Professor in Clinical Psychiatry – Division of Consultation-Liaison Psychiatry at Columbia University Irving Medical Center/New York-Presbyterian Hospital - and co-chair of the HIV/AIDS Section of the World Psychiatric Association.
Ignacio Pérez-Valero, MD, Ph. D.
Ignacio Pérez-Valero, MD, Ph. D.
Ignacio Pérez-Valero MD PhD is a 41 years-old Consultant Physician of Internal Medicine at the La Paz University Hospital and a Senior Clinical Researcher at the IDIPAZ Research Institute (Madrid, Spain).
Judith Rosmalen, MD
Judith Rosmalen, MD
Prof. Dr. J. (Judith) G.M. Rosmalen is appointed as a professor in psychosomatic medicine at the departments of Psychiatry and Internal medicine of the University Medical Center Groningen. She studied medical biology (University of Utrecht 1995) and psychology (University of Leiden 1998, cum laude), and obtained her PhD on interactions between immune and endocrine system (Erasmus University Rotterdam 2000). Her multidisciplinary research focusses on interactions between biomedical and psychosocial aspects of health problems, with a focus on medically unexplained symptoms. She is project leader of the consortium developing the online expert system Grip. This system provides an innovative personalised treatment for medically unexplained symptoms. She is the chair of the Dutch national network on medically unexplained symptoms.
Milton Wainberg, MD
Milton Wainberg, MD
Milton Wainberg is Professor of Clinical Psychiatry and Director of Global Mental Health Research in the Department of Psychiatry, Columbia University. He is Director of the NIMH-funded Columbia University Global Mental Health Implementation Science T32-Post Doctoral Fellowship, NIMH/Fogarty International-funded Portuguese-speaking African countries Mental Health Implementation Research Training Program, Founding Chair of the Caucus of Global Mental Health and Psychiatry of the American Psychiatric Association, and Medical Director of the Columbia University HIV Mental Health Training Project. Dr. Wainberg is the Chair of the Mental Health HIV Clinical Guidelines Committee of the New York State Department of Health/AIDS Institute, and has been Principal investigator or investigator of multiple NIMH, NIAAA, NIDA and CDC studies addressing the intersection of mental illness, substance use and abuse, HIV-associated fatigue, sexual compulsivity and HIV prevention and adherence to care, as well as the stigma and discrimination associated with mental illness, HIV, race/ethnicity and being a sexual minority. Dr. Wainberg is the Principal Investigators of the NIMH-funded PRIDE sSA - Partnerships in Research to Implement and Disseminate Sustainable and Scalable Evidence-based Practices: sub-Saharan Africa which comprises a large scale up study delivering comprehensive efficacious and sustainable psychiatric care in three Provinces of Mozambique, and capacity building of a collaborative research network that will train service providers, investigators and policy-makers from Botswana, Malawi, Mozambique, South Africa, Zambia.  His research to practice work aims to decrease the global mental health treatment and research gaps.
Alan Winston, MD.
Alan Winston, MD.
Dr.Winston is a Clinical Senior Lecturer in Communicable Diseases at Imperial College, London and Consultant Physician in HIV and GU Medicine at St. Mary’s Hospital, London. Dr.Winston is a clinical researcher with an MD in clinical pharmacology and runs a portfolio of clinical trials assessing non-infectious co-morbidities, including cerebral function, in relation to HIV disease with a focus on antiretroviral pharmacokinetics and pharmacodynamics in sanctuary sites.

View Programme